Sentences with phrase «decreases in revenue caused»

Both hospitals fall under the umbrella of the Greater Hudson Valley Health System, which announced the cuts on Monday due to substantial reductions in reimbursement from the federal and state governments and decreases in revenue caused by healthcare reform.

Not exact matches

The ratio increased from 3.27 times at Q4 2017 due to the decrease in twelve - month rolling EBITDA caused by the lower revenue (mainly FX impact, periodic and Other revenue), the IFRS 15 accounting change and the restructuring provision.

This increased from 3.27 times at Q4 2017 due mainly to the decrease in 12 - month rolling EBITDA caused by FX, lower periodic and other revenue, IFRS 15 accounting change and the restructuring provision, as well as the higher proportion of capital expenditure and interest payments in Q1 2018.

These risks and uncertainties include: Gilead's ability to achieve its anticipated full year 2018 financial results; Gilead's ability to sustain growth in revenues for its antiviral and other programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (the SEC).

To a large extent, state fiscal policies have caused great pressure on property taxes in needy cities, counties and school districts, including decisions: to reduce revenue sharing; to decrease the share of local school budgets covered by state aid, to divide the non-federal share of Medicaid costs without considering ability to pay, and to allocate STAR benefits... (read more)

While some publishers have noticed a leveling out on their digital sales, especially following circumstances like the hype over a particular ebook decreasing and causing a resulting minor drop in digital sales, others are still reporting record increases in revenue from digital publishing.

The decreases from the prior quarter — or the decrease from the prior quarter was due to the adoption of the revenue - recognition standard, which caused expenses to decrease by $ 9 million and lower distribution expense of $ 1.7 million from two fewer days in the quarter, offset by higher comp and related expense from incentive compensation and seasonally higher payroll taxes.